Considering that Aspen Aerogels opened Friday and Nordic American opened Thursday, it is arguable that these are substantial losses. But IPO investors experience the good with the bad.
Abengoa Yield, Memorial Resource Development, Mobile Iron, and Zhaopin all launched into existence with gains in excess of 10 percent. During one day of trading Abengoa exploded, returning almost 28 percent to investors who received IPO shares. Memorial Resource, Mobile Iron, and Zhaopin returned 16.6 percent, 15.8 percent, and 13.9 percent respectively. The two IPO losses don't look so bad when compared to these types of returns.
This week, investors hope to build on those gains with 14 IPOs expected.
IPOs for the week of June 16
Expected for Wednesday, June 18
Expected for Thursday, June 19
Expected for Friday, June 20
With fourteen new issues in one week, IPO investors can hope to close the books next Friday and look at the performance of the S&P with pity.
Disclosure: At the time of this writing, the author holds no positions in the mentioned securities.
- Century Communities CCS: 4.5 million shares expected between $23 and $26 through FBR, J.P. Morgan, and DB Markets.
- Foresight Energy FELP: 17.5 million shares expected between $19 and $21 through Barclays, Citigroup, Morgan Stanley, Goldman Sachs, J.P. Morgan, and Deutsche Bank.
- Microlin Bio MCLB: 2.7 million shares expected for the range between $10 and $12 through Brean Capital and Summer Street.
- Parnell PARN: 3.6 million shares are expected to price between $17 and $19 through Jefferies and Piper Jaffray.
- Signal Genetics SGNL: Originally expected to price the week of June 9, Signal Genetics is expected to price 1.5 million shares between $10 and $12.
- Viper Energy VNOM: 5 million shares are expected to price between $19 and $21 through Barclays, Credit Suisse, and Wells Fargo.
- ZS Pharma ZSPH: 5 million shares are expected to price between $15 and $17 through J.P. Morgan and Credit Suisse.
- Performance Sports Group PSG: $135 million offering is expected to price through Morgan Stanley, BofA Merrill Lynch, and RBC. The company currently trades on TSX as Bauer Performance Sports, but is looking to list in the US on the NYSE.
- Eclipse Resources ECR: 30.3 million shares are expected to price between $27 and $30 through Citigroup, Goldman Sachs, and Morgan Stanley.
- Kite Pharma KITE: 6 million shares are slated to price between $12 and $14 through Jefferies, Credit Suisse, and Cowen and Company.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.